Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07646483
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee OsteoarthritisPharmaResearch Co.,LtdNot Yet RecruitingNot Applicable
NCT07646483Not Yet Recruiting
Not Applicable
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and...PharmaResearch Co.,Ltd
NCT07645755
CRETA (Clopidogrel Responsiveness in Essential ThrombocithemiA)Fondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07645755Not Yet Recruiting
—
CRETA (Clopidogrel Responsiveness in Essential ThrombocithemiA)Fondazione Policlinico Un...
NCT07645586
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 3
NCT07645586Not Yet Recruiting
Phase 3
A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After A...Beijing Tiantan Hospital
NCT07644403
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.Suzhou Immunofoco Biotechnology Co., LtdEnrolling By InvitationPhase 1
NCT07644403Enrolling By Invitation
Phase 1
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid...Suzhou Immunofoco Biotech...
NCT07645534
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.Valenta Pharm JSCRecruitingPhase 1
NCT07645534Recruiting
Phase 1
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta...Valenta Pharm JSC
NCT07644650
Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant TumorsMabsoft Therapeutics (Australia) Pty. Ltd.Not Yet RecruitingPhase 1
NCT07644650Not Yet Recruiting
Phase 1
Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant TumorsMabsoft Therapeutics (Aus...
NCT07645690
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell CarcinomaChinese PLA General HospitalRecruitingEarly Phase 1
NCT07645690Recruiting
Early Phase 1
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Meta...Chinese PLA General Hospi...
NCT07645144
FES-assisted Gait Training for Incomplete Spinal Cord InjuryStichting ReadeEnrolling By InvitationNot Applicable
NCT07645144Enrolling By Invitation
Not Applicable
FES-assisted Gait Training for Incomplete Spinal Cord InjuryStichting Reade
NCT07644338
The Efficacy and Safety of Temporal Interference Stimulation in the Treatment of Post-Traumatic Stress DisorderShanghai Mental Health CenterRecruitingNot Applicable
NCT07644338Recruiting
Not Applicable
The Efficacy and Safety of Temporal Interference Stimulation in the Treatment of...Shanghai Mental Health Ce...
NCT07644000
Effect of Pre-exercise Inhalation of Molecular Hydrogen on Metabolic Response During Graded Exercise in Healthy WomenPalacky UniversityNot Yet RecruitingNot Applicable
NCT07644000Not Yet Recruiting
Not Applicable
Effect of Pre-exercise Inhalation of Molecular Hydrogen on Metabolic Response Du...Palacky University
NCT07645092
Vertebral Augmentation and Percutaneous Fixation for Thoracolumbar Burst Fractures Requiring CorpectomyUniversity Hospital, GrenobleNot Yet Recruiting
NCT07645092Not Yet Recruiting
—
Vertebral Augmentation and Percutaneous Fixation for Thoracolumbar Burst Fractur...University Hospital, Gren...
NCT07645573
18F-FTHA IMAGING OF THE INTESTINAL AND CENTRAL LYMPHATIC SYSTEMUniversity of PennsylvaniaRecruitingEarly Phase 1
NCT07645573Recruiting
Early Phase 1
18F-FTHA IMAGING OF THE INTESTINAL AND CENTRAL LYMPHATIC SYSTEMUniversity of Pennsylvani...
NCT07644182
Neuman Systems Model-Based Yoga Therapy for Test Anxiety in Secondary School StudentsPamukkale UniversityCompletedNot Applicable
NCT07644182Completed
Not Applicable
Neuman Systems Model-Based Yoga Therapy for Test Anxiety in Secondary School Stu...Pamukkale University
NCT07643805
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLThe First Affiliated Hospital with Nanjing Medical UniversityNot Yet RecruitingPhase 1
NCT07643805Not Yet Recruiting
Phase 1
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Pat...The First Affiliated Hosp...
NCT07646327
Sustained Natural Apophyseal Glides With and Without Facilitated Positional Release Technique in Cervicogenic DizzinessRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646327Not Yet Recruiting
Not Applicable
Sustained Natural Apophyseal Glides With and Without Facilitated Positional Rele...Riphah International Univ...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07644351
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia PatientsNovartis PharmaceuticalsCompleted
NCT07644351Completed
—
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lym...Novartis Pharmaceuticals
NCT07645274
Improving Mental Healthcare Outcomes for Minoritized Veterans Through a Peer-led, Patient Navigation Program (PARTNER-MH 2.0)Indiana UniversityNot Yet RecruitingNot Applicable
NCT07645274Not Yet Recruiting
Not Applicable
Improving Mental Healthcare Outcomes for Minoritized Veterans Through a Peer-led...Indiana University
NCT07644572
Individualized Nutrition Intervention in Children With Cerebral PalsyGazi UniversityEnrolling By InvitationNot Applicable
NCT07644572Enrolling By Invitation
Not Applicable
Individualized Nutrition Intervention in Children With Cerebral PalsyGazi University
Result Breakdown
Not yet recruiting9 (45%)
Recruiting6 (30%)
Enrolling by invitation3 (15%)
Completed2 (10%)
not_applicable8 (40%)
Not Specified4 (20%)
Phase 14 (20%)
Early Phase 12 (10%)
Phase 31 (5%)
Phase 21 (5%)